Anxiety disorders collectively represent the most common mental health diagnoses in the United States, affecting approximately 40 million adults — yet a substantial proportion of those patients do not achieve remission with first-line treatments such as SSRIs, SNRIs, and cognitive behavioral therapy. For patients in Jacksonville and Northeast Florida who have not found adequate relief through conventional approaches, IV ketamine therapy is an emerging option backed by growing clinical research. At Ketamine Wellness Institute Jacksonville, we offer IV ketamine under direct physician supervision, and we want patients to have a clear, evidence-based picture of what the current evidence supports before they seek a consultation.
The Neurobiology of Chronic Anxiety
Anxiety disorders encompass a spectrum of diagnoses — generalized anxiety disorder, social anxiety disorder, panic disorder, agoraphobia, and specific phobias among them — and they vary in their underlying neurobiology and responsiveness to treatment. What connects many of these presentations is a pattern of hyperactivated threat detection: the amygdala signals danger disproportionately to actual risk, the prefrontal cortex struggles to apply rational context that would suppress the response, and the nervous system maintains a chronic state of physiological readiness that exhausts and dysregulates the patient over time. Standard pharmacological treatments target monoamine neurotransmitter systems — primarily serotonin and GABA — but these mechanisms do not address dysregulation in the glutamate system, which plays a significant role in fear conditioning and threat anticipation.
The Role of Glutamate and Ketamine’s Mechanism
Ketamine’s primary mechanism — NMDA receptor blockade in the glutamate system — is directly relevant to this gap. Research published in neuropsychiatry journals has described ketamine’s ability to produce rapid reductions in anxiety symptom scores, in some cases within hours of infusion, suggesting a speed of action that reflects a mechanistic difference from monoamine-targeting drugs. The theoretical framework involves ketamine’s promotion of synaptogenesis in the prefrontal cortex and hippocampus — regions associated with contextualizing threat and applying inhibitory control to the amygdala — potentially restoring the regulatory capacity that chronic anxiety has diminished. The science behind ketamine for anxiety is supported by research but not clinically established as the definitive mechanism, and IV ketamine for anxiety disorders is off-label — not FDA-approved for these indications. Results vary by individual.
The Clinical Framework at Our Jacksonville Practice
Dr. Aravind Reddy, MD, who leads our clinic, applies his dual board certification in anesthesiology and interventional pain medicine to every infusion, including patients presenting primarily with anxiety. Anxiety patients often carry complex clinical histories — prior medication trials, comorbid depression, histories of trauma, and sometimes prior adverse experiences in medical settings — that require a physician with the training and attentiveness to assess and manage each case individually. Dr. Reddy’s direct presence at every infusion is not a logistical detail; it is a clinical commitment that shapes the quality of care throughout the session.
Navigating the Dissociative Infusion Experience
The question we hear most frequently from anxiety patients is whether the ketamine experience itself will make their anxiety worse. This is a legitimate concern. The dissociative state produced by IV ketamine — altered time perception, perceptual changes, disconnection from ordinary thought — is unfamiliar and can trigger anxiety in patients whose primary distress is already a felt loss of control or safety. We address this concern directly in the intake process: we explain what the experience typically involves, what our clinical team is monitoring throughout, and what grounding approaches may help during the session. Dr. Reddy’s pharmacological expertise means that the infusion parameters — dose, rate, duration — are calibrated with the patient’s anxiety history in mind. Many patients who enter the first session with significant anticipatory anxiety report that with adequate preparation and the knowledge that a physician is present, the experience is more manageable than they expected. Discuss with your provider in advance how your specific anxiety presentation and any prior adverse experiences in medical settings should shape the preparation approach.
Financial Considerations and Comorbidities
Cost is a significant barrier for anxiety patients, and we want to address it honestly. IV ketamine for anxiety is off-label, and coverage through most commercial insurance plans is unavailable for psychiatric indications. The out-of-pocket investment is real, and we encourage patients to have a frank conversation about it during the consultation rather than after committing to a treatment plan. For patients who carry comorbid depression alongside anxiety — a very common presentation — the clinical picture may be more complex and should be assessed individually to determine whether the treatment plan should address both dimensions and how. Discuss with your provider whether your specific diagnostic profile affects any aspect of treatment planning.
Optimizing Treatment Safety and Long-Term Success
One important clinical point for anxiety patients considering ketamine: certain commonly prescribed anxiolytic medications — particularly benzodiazepines — may interact with ketamine and potentially reduce its efficacy by competing with or modulating glutamate system signaling. Our intake evaluation includes a thorough medication review, and Dr. Reddy advises patients on any considerations regarding their current regimen before beginning infusions. We do not advise patients to stop medications without the involvement of their current prescriber; any changes are managed collaboratively and carefully. Patients with questions about combining medications can also review our guidance on taking ketamine while on antidepressants for additional context.
Maximizing Results with Concurrent Psychotherapy
We recognize that anxiety, perhaps more than any other condition, is sustained and amplified between sessions by cognitive patterns, avoidance behaviors, and somatic hyperarousal that ketamine alone does not address. The neuroplastic window opened by ketamine may be most valuable when psychological work — with a licensed therapist who can help patients process what arises and develop new behavioral responses — accompanies the infusion series. We do not provide in-house psychotherapy, but we actively encourage patients to maintain or establish a therapeutic relationship with a licensed mental health provider as an essential part of the overall treatment plan. We can discuss referral resources during the consultation.
Patient Resources and Frequently Asked Questions
Frequently Asked Questions
Is ketamine approved for anxiety disorders?
No. IV ketamine’s use for anxiety disorders is off-label and not FDA-approved for these indications. The research base is growing, with studies reporting rapid anxiety symptom reduction in certain populations, but it has not reached the level required for FDA approval. We explain this clearly during every intake. Discuss with your provider whether the evidence level and off-label status are factors you want to weigh in your decision.
Will the dissociative experience from ketamine make my anxiety worse?
Some patients do experience anticipatory anxiety about the unfamiliarity of the ketamine state. With thorough preparation — including a detailed explanation of what to expect, calibration of infusion parameters to your history, and Dr. Reddy’s direct presence throughout — many anxious patients navigate the experience without it exacerbating their anxiety. Preparation is a genuine clinical priority in our intake process, not a formality.
Can I take my anxiety medication on the day of infusion?
This depends on your specific medication. Certain anxiolytics, particularly benzodiazepines, may interact with ketamine. Our intake evaluation includes a full medication review, and Dr. Reddy will provide specific guidance before your first session. Do not modify any medications without discussing with your prescriber and our team.
How many sessions are needed for anxiety treatment with ketamine?
The standard six-infusion induction protocol over two to three weeks is the starting point. Anxiety responses to ketamine can be more variable than depression responses, and the appropriate number and frequency of sessions are determined through ongoing clinical assessment with Dr. Reddy. Results vary by individual.
Should I be in therapy while receiving ketamine for anxiety?
We strongly encourage patients to have a licensed therapist supporting their care alongside ketamine treatment. Ketamine may create a period of heightened neuroplasticity; working with that neuroplastic window through psychological processing tends to produce more durable benefit than pharmacological treatment alone. We can discuss referral resources during your consultation.
Key Takeaways
- Anxiety disorders involve glutamate system dysregulation alongside monoamine imbalances; ketamine’s NMDA receptor mechanism addresses the glutamate component that standard treatments do not
- IV ketamine for anxiety is off-label; growing research supports its use, but FDA approval has not been granted for these indications
- Preparation — calibrating the infusion approach and clinical environment to each patient’s anxiety history — is a clinical priority, not an afterthought
- Concurrent psychotherapy is strongly encouraged to make use of the neuroplastic window ketamine creates
- Results vary by individual; discuss your full clinical history, current medications, and treatment goals with your provider before beginning
Conclusion
Anxiety that has not responded to standard treatments deserves a clinically serious alternative — and IV ketamine, administered by a physician with the training to manage the infusion safely and the attentiveness to individualize care, may provide that alternative. If you are in Jacksonville or Northeast Florida and have not found adequate relief through conventional anxiety treatment, we invite you to schedule a consultation at Ketamine Wellness Institute Jacksonville to explore whether IV ketamine belongs in your plan.
About Dr. Aravind Reddy, MD
Dr. Aravind Reddy is a double board-certified anesthesiologist and interventional pain medicine specialist who leads Ketamine Wellness Institute Jacksonville. He completed his residency and fellowship in pain management at the University of North Carolina in Chapel Hill. Born and raised in Tallahassee, Florida, Dr. Reddy returned to North Florida to serve the Jacksonville community. He is committed to compassionate, multi-disciplinary care for patients with complex pain and mental health conditions, providing direct physician oversight at every ketamine infusion session. The clinic operates from Jacksonville Beach and serves patients across the Northeast Florida region.
References
Anxiety and Depression Association of America — https://adaa.org/understanding-anxiety
National Institute of Mental Health — https://www.nimh.nih.gov/health/topics/anxiety-disorders
American Psychiatric Association — https://www.psychiatry.org/patients-families/anxiety-disorders
American Society of Ketamine Physicians, Psychotherapists & Practitioners — https://www.askp3.org/
Medical Disclaimer
The content of this article is provided by Ketamine Wellness Institute Jacksonville for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Ketamine’s use for anxiety disorders is off-label and not FDA-approved for these indications. Individual results vary. Always discuss treatment options, risks, and benefits with a qualified healthcare provider before making any medical decisions.